Turnover: 782.2 million EUR (2023)
Country: Italy
Allergan plc is an Irish-based pharmaceutical company with operations in 100 countries worldwide. Its business portfolio includes several therapeutic areas, namely central nervous system, ophthalmology, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infectives.
In France, more than 500 employees work for the Allergan group, both in the sales office located in La Défense in Paris and in its R&D center in Paris
In 2007, the group acquired the Cornéal laboratory for 170 million euros, resulting in the wrinkle-filling treatment Juvederm.
News
Medicine, Allergan Aesthetics launches training center for healthcare professionals 26/06/2023
Inauguration of Allergan Aesthetics' Center of Excellence in Italy, specifically in Rome. This center represents the first and only space completely dedicated to both theoretical and practical training of healthcare professionals. Its foundation is supported by the expertise of a multidisciplinary scientific committee composed of 21 nationally and internationally renowned experts. The main goal of the center is to offer high-quality training to healthcare professionals through 4 complementary curricula in order to ensure maximum satisfaction of their patients.
Financial Data
DUNS: 312856917
Legal Name: ALLERGAN FRANCE
Address: 1 PASSERELLE DES REFLETS TOUR CBX, 92400 COURBEVOIE
Number of employees: 0 salarié (2022)
Capital: 133 170 EUR
Financial Data:
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Turnover | 209 385 039 | 194 199 277 | 215 941 842 | 212 713 919 | 218 592 144 | 209 613 514 |
| Gross margin (€) | 75 370 829 | 65 477 206 | 66 902 246 | 68 671 802 | 69 205 739 | 68 775 615 |
| EBITDA (€) | 8 791 125 | 5 897 779 | 8 116 248 | 9 039 148 | 6 914 538 | 8 134 428 |
| Operating profit (€) | 10 262 226 | 7 594 014 | 9 608 070 | 9 603 984 | 9 886 324 | 11 733 463 |
| Net profit (€) | 4 119 380 | 3 258 017 | 3 277 610 | 3 621 350 | 4 205 342 | 5 487 478 |
| Turnover growth rate (%) | 7,8 | -10,1 | 1,5 | -2,7 | 4,3 | 7,1 |
| Ebitda margin rate (%) | 4,2 | 3 | 3,8 | 4,2 | 3,2 | 3,9 |
| Operating margin rate (%) | 4,9 | 3,9 | 4,4 | 4,5 | 4,5 | 5,6 |
| Working Capital (turnover days) | -28,3 | -31,4 | -19,5 | -17,7 | 13,8 | 12,3 |
| Working Capital requirements (turnover days) | 16,4 | 1,8 | 11,1 | 12,3 | 13,5 | 17,6 |
| Net margin (%) | 2 | 1,7 | 1,5 | 1,7 | 1,9 | 2,6 |
| Added value / Turnover (%) | 24 | 24 | 20,6 | 22,2 | 20,9 | 21,4 |
| Wages and social charges (€) | 29 742 303 | 29 280 141 | 27 890 951 | 27 830 122 | 28 321 529 | 27 251 398 |
| Salaries / Turnover (%) | 14,2 | 15,1 | 12,9 | 13,1 | 13 | 13 |
Company Managers:
| Position | First Name | Last Name | Age | |
|---|---|---|---|---|
| Président | Stephane, Charles | Lassignardie | 54 | |
| Directeur général | Thierry, Georges | Souchon | 60 |
Studies mentioning this company
The aesthetic medicine market - France
Other companies mentioned:
- Allergan plc (Abbvie)
- Galderma
- Merz Pharmaceuticals
- La Roche-Posay
- Filorga Cosmétiques (Colgate Palmolive)
- Lierac (Laboratoire Native)
- Laboratoires Sebbin
- Arion
- Candela Medical
- Deleo
- Ipsen
- Clinique des Champs Elysées
- Lazeo
- Maison Lutetia
- Skincareagency
- Healshape
The aesthetic medicine market - Brazil
Other companies mentioned:
- Allergan plc (Abbvie)
- La Roche-Posay
- Laboratoires Sebbin
- Arion
The aesthetic medicine market - Portugal
Other companies mentioned:
- Allergan plc (Abbvie)
- La Roche-Posay
- Laboratoires Sebbin
- Arion
- Filorga Cosmétiques (Colgate Palmolive)
The aesthetic medicine market - United Kingdom
Other companies mentioned:
- Allergan plc (Abbvie)
- Ipsen
- Merz Pharmaceuticals
- Cynosure
- Alma Lasers
The aesthetic medicine market - Italy
Other companies mentioned:
- Fidia Farmaceutici
- Decomedical
- ITS Group
- BTL
- EME Estetica
- Ipsen
- Merz Pharmaceuticals
- Allergan plc (Abbvie)